Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-03

Clinical Trial Update: Efficacy and Safety of Mebeverine + Simethicone in Patients With Functional Bowel Disorders [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of a fixed combination of mebeverine and simethicone in patients with functional bowel disorders has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mebeverine + Simethicone (Mebeverine and Simethicone)

Snippet

Sponsor: Abbott | Conditions: Functional Bowel Disorder | Phase 3 | Status: COMPLETED | Results posted: 2024-01-03